Fulcrum Therapeutics
(NASDAQ:FULC)
$6.85
0.01[0.15%]
At close: Nov 25(Delayed 15-Minutes)
Get Real Time Here
$6.85
After Hours: 1:01PM EDT
Day Range6.68 - 7.0452 Wk Range3.21 - 24.79Open / Close6.85 / 6.85Float / Outstanding39M / 52.1M
Vol / Avg.149.2K / 387.6KMkt Cap356.6MP/E-50d Avg. Price7.06
Div / Yield-Payout Ratio-Total Float39MEPS-0.51

Fulcrum Therapeutics Stock (NASDAQ:FULC), Earnings Estimates, EPS, and Revenue

Fulcrum Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 8

EPS

$-0.510

Quarterly Revenue

$1.2M

Annual Revenue (as of Sep 30)

$10.7M

Earnings History

Analyze the earnings history of Fulcrum Therapeutics using advanced sorting and filters.

Date
time
Quarter
Prior EPS
Est EPS
Actual EPS
EPS Surprise
Prior Rev
Est Rev
Actual Rev
Rev Surprise
Get Alert
Q

When is Fulcrum Therapeutics (NASDAQ:FULC) reporting earnings?

A

Fulcrum Therapeutics (FULC) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 8, 2022 for Q3.

Q

What were the latest earnings per share (EPS) for Fulcrum Therapeutics (NASDAQ:FULC)?

A

Fulcrum Therapeutics (FULC) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on August 26, 2019 for Q2 and the Actual EPS was $-9.21, which missed the estimate of $-3.10.

Q

What were Fulcrum Therapeutics’s (NASDAQ:FULC) revenues?

A

Fulcrum Therapeutics (FULC) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on August 26, 2019 for Q2 and the Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.